Zamansky Dmitry
Known title: Chief Product & Tech. OfficerCIK: 0002059643
Associated companies
Transaction History
| AMWL | ▼ Sell | Open Market | 8,442 | $110K | 10/1/2026 | View on chart |
| AMWL | ▼ Sell | Open Market | 8,460 | $79K | 7/1/2026 | View on chart |
| AMWL | ▼ Sell | Open Market | 5,575 | $30K | 4/1/2026 | View on chart |
| AMWL | ▲ Buy | Grant | 50,413 | $0 | 3/4/2026 | View on chart |
| AMWL | ▼ Sell | Open Market | 2,472 | $13K | 3/2/2026 | View on chart |
| AMWL | ▼ Sell | Open Market | 6,243 | $30K | 1/2/2026 | View on chart |
| AMWL | ▼ Sell | Open Market | 25,605 | $173K | 9/3/2025 | View on chart |
| AMWL | ▲ Buy | Grant | 220,844 | $0 | 3/3/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Doximity AI investment news highlights AMWL sector context
Recent coverage focuses on Doximity's ability to shrink its share count through AI investments. This is relevant to AMWL as it highlights broader trends in the healthcare technology sector. While no direct news was reported for American Well, the sector focus provides context for its current trading position.
Doximity AI investment news highlights AMWL sector context. Recent coverage focuses on Doximity's ability to shrink its share count through AI investments. This is relevant to AMWL as it highlights broader trends in the healthcare technology sector. While no direct news was reported for American Well, the sector focus provides context for its current trading position.